Subscribe

What are you looking for?

Main Menu

明報新聞網

復星醫藥與Clavis Bio簽訂合作及選擇權協議

Future Wealths
Future Wealths
18 12 月, 2025
One Min Read
12 Views
0 Comments
復星醫藥（2196）宣布，旗下復星醫藥產業與生物技術公司Clavis Bio, Inc.達成戰略合作，雙方將基於由Clavis Bio提名的前沿靶點共同開發創新療法。Clavis Bio系Aditum Bio旗下基金為本次合作設立的全資控股子公司。

原文: https://finance.mingpao.com/fin/instantf/20251218/1766060820314/%e5%be%a9%e6%98%9f%e9%86%ab%e8%97%a5%e8%88%87clavis-bio%e7%b0%bd%e8%a8%82%e5%90%88%e4%bd%9c%e5%8f%8a%e9%81%b8%e6%93%87%e6%ac%8a%e5%8d%94%e8%ad%b0

Last Update: 18 12 月, 2025

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept